Concepedia

Julia Yemelyanenko

JY

3

Publications

163

Citations

3

H-Index

2020

Active since

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Amsterdam University Medical Centers

Vrije Universiteit Amsterdam

Julia Yemelyanenko is an author at Oncode Institute specializing in tumor microenvironment, cancer therapeutics, and tumor biology.

ORCID

Top concepts

Publications per year

2020–2023

3

Publications

3

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko et al. · Nature · 2022 · 124 citations · Full text

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao et al. · The Journal of Experimental Medicine · 2023 · 23 citations · Full text

, , +16

Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system

Sjoerd Klarenbeek, Chris W. Doornebal, Sjors M. Kas et al. · OncoImmunology · 2020 · 16 citations · Full text

Rows per page

1–3 of 3